MedPath

Investigating the effect of Zinc Supplement on mood, anxiety and quality of life in the elderly

Not Applicable
Conditions
Condition 1: Mood (depression). Condition 2: Anxiety. Condition 3: Quality of life.
Mood [affective] disorders
Organic anxiety disorder
Lifestyle-related condition
F30-F39
Registration Number
IRCT2017071635110N1
Lead Sponsor
Vice chancellor for research - Shahroud University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

The inclusion criteria for this study are: having full satisfaction to participate in this study; seniors 60 years and older; Iranian citizenship; the ability to speak Farsi and answer questions; not using Zinc Supplement; no cognitive impairment (for the elderly with literacy based on the MMSE questionnaire score 25 and more and for the illiterate elderly, based on the AMTS questionnaire, score 7 and more); lack of liver and intestinal diseases as well as the absence of known cases of depression and anxiety both of these are diagnosed by the doctor. People with serum zinc levels in them based on experiment within be normal range; in that sense people whose serum zinc level is higher or lower than normal range do not enter the study.The exclusion criteria for this study are: the lack of cooperation and refusal of the elderly to continue to participate in research; the consumption of zinc supplement in the control group during the course of 70 days of intervention; the occurrence of severe stress, such as hospitalization or death of relatives in both groups during the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mood(depression). Timepoint: Before the intervention and 70 days after the intervention began. Method of measurement: GDS standard questionnaire.;Anxiety. Timepoint: Before the intervention and 70 days after the intervention began. Method of measurement: BAI standard questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: Before the intervention and 70 days after the intervention began. Method of measurement: SF-36 standard questionnaire.
© Copyright 2025. All Rights Reserved by MedPath